Certmedica partners with digital health startup XO Life to support sustainable weight reduction and control

Certmedica, a company in the development, manufacture and global distribution of medical products, and XO Life, a Munich-based pioneering digital health startup, announced their collaboration in the interests of progressive healthcare.

With formoline L112 and formoline L112 EXTRA, Certmedica has the most recommended and millions of times used slimming products from German pharmacies in its product portfolio. Users of the active fiber L112 can now use XO Life's ImpactMonitor™ platform. The meta-platform provides digital therapy support for treatment with the lipid binder (fat binder) and offers additional support in the treatment of obesity and weight control.

According to Statista, millions of people in Germany want to lose weight. Diets and exercise programs alone do not always lead to the desired weight loss result. In cases of stubborn excess weight or the yo-yo effect, the certified medical products formoline L112 and formoline L112 EXTRA provide support for sustainable weight reduction and control. The active fiber L112 from natural sources binds a large part of the dietary fats in the gastrointestinal tract and thus reduces calorie intake.

In order to support users of formoline L112 and formoline L112 EXTRA on their way to a healthy and personal comfortable weight, they now have access to the Certmedica formoline L112 product area on the ImpactMonitor™ platform from XO Life after registering free of charge. In the exclusive area, Certmedica customers are offered information specifically about the medical product L112 and other tips for losing weight after logging in. This optimally complements the intake of the active fiber. Users can continuously and measurably track their weight, compare the treatment with others and make individual adjustments to achieve their goals. The information provided in the digital treatment support also allows users to learn more about how the lipid binder works, which improves their understanding, increases motivation and can support them on the way to their personal comfortable weight.

Irmgard van Rensen, Head of Medicine and Communication, Certmedica: "formoline L112 and formoline L112 EXTRA help people to lose weight healthily in order to reach or maintain their ideal weight. Thanks to the Impact Monitor™ platform, our customers now have an additional option to closely monitor their progress and better understand the background of the therapy. The user-friendly interface offers a clear, informative overview and helps to successfully complete the treatment and stay motivated."

Friderike Bruchmann, Co-founder and CEO, XO Life: "The collaboration between Certmedica and XO Life sets new standards for sustainable weight loss and helps achieve weight loss goals. We are pleased to support formoline L112 customers with free digital support on an issue that is as important for personal well-being as weight loss."

www.xo-life.com
www.certmedica.com

Follow Marketing Report on LinkedIn